Company intelligence / Profile preview

CRV

Cambridge, Massachusetts, United Statescrv.com ↗

Ownership: Private
Development stage: Other

Overview

Charles River Ventures (now known as CRV) was founded in 1970 to commercialize research from MIT. It has raised over $4.3 billion across 18 funds and focuses on early-stage investments primarily in technology sectors, including some bioengineering and medtech/life science startups since at least 2018. While it has invested in health IT and biotechnology companies such as Color, Freenome, Amino Health, Health IQ, and cancer immunotherapy startup 3T Biosciences, it does not itself conduct R&D or own therapeutic programs[4][7].

Industry: Investors

Partnerships

Investments include partnerships with portfolio companies such as Color Genomics and Freenome; no direct pharma development partnerships.

Beyond the preview

Go deeper on CRV.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CRV.

Explore the full profile